UnitedHealth Group (NYSE:UNH) had its target price lifted by BMO Capital Markets to $310.00 in a note issued to investors on Thursday, The Fly reports. The brokerage currently has an “outperform” rating on the healthcare conglomerate’s stock. BMO Capital Markets’ price objective suggests a potential upside of 16.85% from the company’s previous close.
A number of other research analysts have also recently issued reports on the company. Citigroup cut UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 target price on the stock. in a research report on Monday, September 10th. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 18th. Raymond James lifted their target price on UnitedHealth Group from $285.00 to $304.00 and gave the company a “strong-buy” rating in a research report on Monday, September 24th. Morgan Stanley lifted their target price on UnitedHealth Group from $278.00 to $305.00 and gave the company an “overweight” rating in a research report on Wednesday, September 5th. Finally, ValuEngine upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday, October 2nd. One research analyst has rated the stock with a hold rating, twenty-three have issued a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $289.41.
Shares of NYSE UNH opened at $265.30 on Thursday. The company has a current ratio of 0.69, a quick ratio of 0.75 and a debt-to-equity ratio of 0.61. UnitedHealth Group has a 52 week low of $203.69 and a 52 week high of $272.81. The firm has a market capitalization of $257.27 billion, a P/E ratio of 26.35, a P/E/G ratio of 1.58 and a beta of 0.73.
In other news, Director William C. Ballard, Jr. sold 10,000 shares of the business’s stock in a transaction dated Wednesday, August 8th. The stock was sold at an average price of $258.83, for a total transaction of $2,588,300.00. Following the sale, the director now directly owns 77,172 shares in the company, valued at $19,974,428.76. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Steven H. Nelson sold 8,142 shares of the business’s stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $265.00, for a total value of $2,157,630.00. Following the sale, the chief executive officer now owns 22,496 shares in the company, valued at $5,961,440. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 94,568 shares of company stock worth $24,950,027. Company insiders own 0.87% of the company’s stock.
Several large investors have recently added to or reduced their stakes in UNH. White Lighthouse Investment Management Inc. acquired a new position in shares of UnitedHealth Group in the second quarter worth approximately $324,000. Wells Fargo & Company MN lifted its stake in shares of UnitedHealth Group by 0.5% in the second quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock worth $1,887,377,000 after acquiring an additional 39,480 shares during the period. Wesbanco Bank Inc. lifted its stake in shares of UnitedHealth Group by 195.2% in the first quarter. Wesbanco Bank Inc. now owns 76,341 shares of the healthcare conglomerate’s stock worth $16,337,000 after acquiring an additional 50,480 shares during the period. Granite Investment Advisors LLC lifted its stake in shares of UnitedHealth Group by 1.4% in the second quarter. Granite Investment Advisors LLC now owns 34,225 shares of the healthcare conglomerate’s stock worth $8,397,000 after acquiring an additional 476 shares during the period. Finally, M Holdings Securities Inc. lifted its stake in shares of UnitedHealth Group by 12.1% in the second quarter. M Holdings Securities Inc. now owns 5,128 shares of the healthcare conglomerate’s stock worth $1,258,000 after acquiring an additional 553 shares during the period. Institutional investors own 85.42% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: Marijuana Stocks
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.